logo
As health grants shrink, memory cafes help dementia patients and caregivers

As health grants shrink, memory cafes help dementia patients and caregivers

Miami Heralda day ago

Rob Kennedy mingled with about a dozen other people in a community space in Clarks Summit, Pennsylvania.
The room, decorated with an under-the-sea theme, had a balloon arch decked out with streamers meant to look like jellyfish and a cloud of clear balloons mimicking ocean bubbles.
Kennedy comes to this memory cafe twice a month since being diagnosed with early onset Alzheimer's disease in his late 50s.
Everyone here has a degree of memory loss or is a caregiver for someone with memory loss.
Attendees colored on worksheets with an underwater theme. They drank coffee and returned to the breakfast bar for seconds on pastries.
A quick round of trivia got everyone's minds working.
'We start out with just little trivia — many of us cannot answer any of the questions,' Kennedy said with a laugh.
'We all have a good time going around,' he added. 'You know, we all try to make it fun.'
The northeastern Pennsylvania memory cafe Kennedy attends is one of more than 600 around the country, according to Dementia Friendly America. The gatherings for people with cognitive impairment and their caregivers are relatively cheap and easy to run — often the only expense is a small rental fee for the space.
As state and local health departments nationwide try to make sense of what the potential loss of $11 billion of federal health funding will mean for the services they can offer their communities, memory cafe organizers believe their work may become even more important.
Losing memory, and other things, too
Kennedy's diagnosis led him to retire, ending a decades-long career as a software engineer at the University of Scranton.
He recommends memory cafes to other people with dementia and their families.
'If they're not coming to a place like this, they're doing themselves a disservice. You got to get out there and see people that are laughing.'
The memory cafes he attends happen twice a month. They have given him purpose, Kennedy said, and help him cope with negative emotions around his diagnosis.
'I came in and I was miserable,' Kennedy said. 'I come in now and it's like, it's family, it's a big, extended family. I get to meet them. I get to meet their partners. I get to meet their children. So, it's really nice.'
More than 6 million people in the U.S. have been diagnosed with some form of dementia. The diagnosis can be burdensome on relationships, particularly with family members who are the primary caregivers.
A new report from the Alzheimer's Association found that 70% of caregivers reported that coordinating care is stressful. Socializing can also become more difficult after diagnosis.
'One thing I have heard again and again from people who come to our memory cafe is 'all of our friends disappeared,'' said Beth Soltzberg, a social worker at Jewish Family and Children's Service of Greater Boston, where she directs the Alzheimer's and related dementia family support program.
The inclusion of caregivers is what distinguishes memory cafes from other programs that serve people with cognitive impairment, like adult day care. Memory cafes don't offer formal therapies. At a memory cafe, having fun together and being social supports the well-being of participants. And that support is for the patient and their caregiver — because both can experience social isolation and distress after a diagnosis.
A 2021 study published in Frontiers in Public Health indicated that even online memory cafes during the pandemic provided social support for both patients and their family members.
'A memory cafe is a cafe which recognizes that some of the clients here may have cognitive impairment, some may not,' said Jason Karlawish, a geriatrics professor at the University of Pennsylvania's Perelman School of Medicine and the co-director of the Penn Memory Center.
Karlawish regularly recommends memory cafes to his patients, in part because they benefit caregivers as well.
'The caregiver-patient dyad, I find often, has achieved some degree of connection and enjoyment in doing things together,' Karlawish said. 'For many, that's a very gratifying experience, because dementia does reshape relationships.'
'That socialization really does help ease the stress that they feel from being a caregiver,' said Kyra O'Brien, a neurologist who also teaches at Penn's Perelman School of Medicine. 'We know that patients have better quality of life when their caregivers are under less stress.'
An affordable way to address a growing problem
As the population grows older, the number of available family caregivers is decreasing, according to the AARP Public Policy Institute. The report found that the number of potential caregivers for an individual 80 or older will decrease significantly by 2050.
In 2024, the Alzheimer's Association issued a report projecting a jump in dementia cases in the U.S. from an estimated 6.9 million people age 65 or older currently living with Alzheimer's disease to 13.8 million people by 2060. It attributed this increase primarily to the aging of the baby boom generation, or those born between 1946 and 1964.
As cases of memory loss are projected to rise, the Trump administration is attempting to cut billions in health spending. Since memory cafes don't rely on federal dollars, they may become an even more important part of the continuum of care for people with memory loss and their loved ones.
'We're fighting off some pretty significant Medicaid cuts at the congressional level,' said Georgia Goodman, director of Medicaid policy for LeadingAge, a national nonprofit network of services for people as they age. 'Medicaid is a program that doesn't necessarily pay for memory cafes, but thinking about ensuring that the long-term care continuum and the funding mechanisms that support it are robust and remain available for folks is going to be key.'
The nonprofit MemoryLane Care Services operates two memory cafes in Toledo, Ohio. They're virtually free to operate, because they take place in venues that don't require payment, according to Salli Bollin, the executive director.
'That really helps from a cost standpoint, from a funding standpoint,' Bollin said.
One of the memory cafes takes place once a month at a local coffee shop. The other meets at the Toledo Museum of Art. MemoryLane Care Services provides the museum employees with training in dementia sensitivity so they can lead tours for the memory cafe participants.
The memory cafe that Rob Kennedy attends in Pennsylvania costs about $150 a month to run, according to the host organization, The Gathering Place.
'This is a labor of love,' said board member Paula Baillie, referring to the volunteers who run the memory cafe. 'The fact that they're giving up time — they recognize that this is important.'
The monthly budget goes toward crafts, books, coffee, snacks, and some utilities for the two-hour meetings. Local foundations provide grants that help cover those costs.
Even though memory cafes are inexpensive and not dependent on federal funding, they could face indirect obstacles because of the Trump administration's recent funding cuts.
Organizers worry the loss of federal funds could negatively affect the host institutions, such as libraries and other community spaces.
Memory cafe hot spot
At least 39 states have hosted memory cafes recently, according to Dementia Friendly America. Wisconsin has the most — more than 100.
The state has a strong infrastructure focused on memory care, which should keep its memory cafes running regardless of what is happening at the federal level, according to Susan McFadden, a professor emerita of psychology at the University of Wisconsin-Oshkosh. She co-founded the Fox Valley Memory Project, which oversees 14 memory cafes.
'They've operated on the grassroots, they've operated on pretty small budgets and a lot of goodwill,' she said.
Since 2013, Wisconsin has also had a unique network for dementia care, with state-funded dementia care specialists for each county and federally recognized tribe in Wisconsin. The specialists help connect individuals with cognitive impairment to community resources, bolstering memory cafe attendance.
McFadden first heard about memory cafes in 2011, before they were popular in the United States. She was conducting research on memory and teaching courses on aging.
McFadden reached out to memory cafes in the United Kingdom, where the model was already popular and well connected. Memory cafe organizers invited her to visit and observe them in person, so she planned a trip overseas with her husband.
Their tour skipped over the typical tourist hot spots, taking them to more humble settings.
'We saw church basements and senior center dining rooms and assisted living dining rooms,' she said. 'That, to me, is really the core of memory cafes. It's hospitality. It's reaching out to people you don't know and welcoming them, and that's what they did for us.'
After her trip, McFadden started applying for grants and scouting locations that could host memory cafes in Wisconsin.
She opened her first one in Appleton, Wisconsin, in 2012, just over a year after her transformative trip to the U.K.
These days, she points interested people to a national directory of memory cafes hosted by Dementia Friendly America. The organization's Memory Cafe Alliance also offers training modules — developed by McFadden and her colleague Anne Basting — to help people establish cafes in their own communities, wherever they are.
'They're not so hard to set up; they're not expensive,' McFadden said. 'It doesn't require an act of the legislature to do a memory cafe. It takes community engagement.'
This article is part of a partnership with NPR and WVIA.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — an independent source of health policy research, polling, and journalism. Learn more about KFF.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer's Disease
Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer's Disease

Yahoo

time6 hours ago

  • Yahoo

Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer's Disease

TAINAN, June 12, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer's disease (AD). TML-6 combines multiple mechanisms, including anti-oxidative effects (Nrf2 activation), melioration of autophagy function (autolysosomal activation), anti-amyloid accumulation (β-amyloid clearance), and anti-inflammatory effects (through NF-κB inhibition) through autolysosome pathway in neurons and microglia to remove intraneuronal and extracellular amyloid accumulation, representing the first in human multi-target strategy for AD treatment. The Phase I trial showed excellent safety, tolerability, and pharmacokinetics at 100–200 mg in both healthy and elderly adults. TML-6 will now advance to a Phase II 19 site trial across the United States, Sweden, and Taiwan after FDA approval. This 12-month study will enroll 210 patients with mild cognitive impairment (MCI) or mild dementia. Primary endpoints will include neuropsychological assessments (CDR-SB, iADRS) and blood biomarkers (p-Tau 217, Aβ42/40, NfL, GFAP), supported by brain MRI, amyloid PET scans, and ApoE genotyping. Type C FDA consultation for phase 2 trial design has completed on 13 May 2025, with trial initiation expected in April 2026, conducted by Syneos Health CRO. With its strong preclinical and clinical profile, TML-6 holds promise as both a monotherapy and in combination with anti-amyloid biologics, providing new hope for patients with Alzheimer's disease. About Merry Life Biomedical Company Merry Life Biomedical is a Taiwan-based biotechnology company focused on developing innovative therapies for neurodegenerative and age-related diseases. Leveraging advanced molecular design, pharmacological innovation, formulation optimization and global clinical development, the company is committed to addressing urgent unmet medical needs. Media ContactDr. Ih-Jen SuMerry Life Biomedical Company, +886-910-902-296Email: suihjen0704@ View original content to download multimedia: SOURCE Merry Life Biomedical Company, Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

RFK Jr. Is Barely Even Pretending Anymore
RFK Jr. Is Barely Even Pretending Anymore

Yahoo

time7 hours ago

  • Yahoo

RFK Jr. Is Barely Even Pretending Anymore

The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here. When Robert F. Kennedy Jr. accepted his new position as health secretary, he made a big show of distancing himself from his past life. 'News reports have claimed that I am anti-vaccine or anti-industry,' Kennedy, who has for decades promoted the debunked notion that vaccines cause autism and has baselessly sown doubt over the ability of the U.S. government to vet shots, said at his confirmation hearing in January. 'I am neither. I am pro-safety.' But for all Kennedy's talk, this week, he did exactly what a person would do if they were trying to undermine the scientific consensus on vaccination in the United States. He abruptly dismissed the entire expert committee that advises the CDC on its nationwide vaccine recommendations—and began to fill the roster with like-minded people ready to cast doubt on the benefits of vaccination. Like Kennedy, few of these new appointees to the Advisory Committee on Immunization Practice, or ACIP, have openly embraced the notion that they are anti-vaccine. But among them are individuals who have spoken out against COVID vaccines and policies, claimed vaccine injuries for their own children, and falsely linked COVID shots to deaths—or even baselessly accused those vaccines of 'causing a form of acquired immunity deficiency syndrome.' In January, I wrote that remaking the committee in exactly this way would be an especially harmful blow to Americans' health: Perhaps more than any other body of experts in the U.S., ACIP guides the nation's future preparedness against infectious disease. By appointing a committee that is poised to legitimize more of his own radical views, Kennedy is giving his skewed version of scientific reality the government's imprimatur. Whether he will admit to it or not, he is serving the most core goal of the anti-vaccine movement—eroding access to, and trust in, immunization. In an emailed statement, Health and Human Services Press Secretary Emily G. Hilliard reiterated that 'Secretary Kennedy is not anti-vaccine—he is pro-safety, pro-transparency, and pro-accountability,' and added that his 'evidence-based approach puts accountability and radical transparency first, which will restore trust in our public health system.' (Kennedy, notably, promised Senator Bill Cassidy during his confirmation process that he would maintain ACIP, as Cassidy put it, 'without changes.') Since the 1960s, ACIP has lent government policy on vaccines the clout of scientific evidence. Its mandate is to convene experts across fields such as infectious disease, immunology, pediatrics, vaccinology, and public health to carefully vet the data on immunizations, weigh their risks and benefits, and vote on recommendations that guide the public on how to use them—who should get vaccines, and when. Those guidelines are then passed to the CDC director, who—with only the rarest of exceptions—accepts that advice wholesale. 'These recommendations are what states look to, what providers look to,' Rupali Limaye, an expert in vaccine behavior at the Johns Hopkins Bloomberg School of Public Health, told me. Medicare, for instance, is required to fully cover the vaccines that ACIP recommends; ACIP also determines which vaccines are covered by the Vaccines for Children Program, which provides free vaccines for children whose families cannot afford them. The experts who serve on ACIP have the opportunity, more than just about any of their scientific peers, to translate their vaccine rhetoric into reality. So far, Kennedy has dismissed the 17 people who were serving on ACIP, and filled eight of the newly open slots. Most of the new nominees have an obvious bone to pick with at least some vaccines, especially COVID shots, and have publicly advocated for limiting their use. Among the new members, for instance, is Robert Malone, a controversial physician who has spoken at anti-vaccine events, where he has denounced COVID vaccines and, without evidence, suggested that they can worsen coronavirus infections. Another appointee is Vicky Pebsworth, who serves on the board of the National Vaccine Information Center, an anti-vaccine nonprofit previously known as Dissatisfied Parents Together. A third, Retsef Levi, a health-care-management expert, called for the administration of COVID vaccines to be halted in 2023, and has questioned the shots' safety, despite a large body of evidence from clinical trials supporting their continued use. Overall, 'this is not a list that would increase confidence in vaccine decisions,' Dorit Reiss, a vaccine-policy expert at UC San Francisco, told me. (None of these new ACIP members returned a request for comment.) The next ACIP meeting is scheduled for the end of this month—and the agenda includes discussion about anthrax vaccines, chikungunya vaccines, COVID-19 vaccines, cytomegalovirus vaccine, the human-papillomavirus vaccine, influenza vaccines, the Lyme-disease vaccine, meningococcal vaccines, pneumococcal vaccines, and RSV vaccines. That's a big slate of topics for a brand-new panel of members, Paul Offit, a pediatrician and a vaccine expert who has previously served on ACIP, told me: Depending on how the meeting is structured, and on the input from CDC scientists, these new committee members could substantially alter the guidelines on several immunizations—perhaps so much so that certain shots could stop being recommended to certain groups of Americans. Based on the composition of the committee so far, Offit predicts that the new ACIP will eventually push the CDC away from full-throated endorsement of many of these vaccines. Even subtle changes in the wording of CDC recommendations—a should swapped for a may—can have big ripple effects, Limaye told me. Insurers, for instance, may be more reluctant to cover vaccines that are not actively endorsed by the CDC; some states—especially those in which vaccines have become a political battleground—may stop mandating those types of shots. If the CDC softens its recommendations, 'we will likely see more partisan divides' in who opts for protection nationwide, Jason Schwartz, a vaccine-policy expert at Yale, told me. Pharmaceutical companies may, in turn, cut down production of vaccines that don't have full CDC backing, perpetuating a cycle of reduced availability and reduced enthusiasm. And primary-care physicians, who look to the CDC's vaccination schedule as an essential reference, may shift the language they use to describe childhood shots, nudging more parents to simply opt out. Historically, medical and public-health associations, such as the American Academy of Pediatrics, have aligned their vaccine recommendations with ACIP's—because those recommendations were all driven by scientific evidence. Now, though, scientific consensus and government position are beginning to diverge: Multiple groups of physicians, scientists, and public-health scholars have issued statements condemning the vaccine decisions of Kennedy and his allies; a number of prominent scientists have now banded together to form a kind of alt-ACIP, dubbing themselves the Vaccine Integrity Project. As the views of fringe vaccine groups become the government's stance, Americans may soon have to choose between following the science and following what their nation's leaders say. Identifying as 'anti-vaccine' has historically been taboo: In a nation where most people remain largely in favor of shots, the term is pejorative, an open acknowledgment that one's views lie outside of the norm. But the more vaccine resistance infiltrates HHS and its advisers, the more what's considered normal may shift toward Kennedy's own views on vaccines; ACIP's reputation for evidence-backed thinking could even gild those views with scientific legitimacy. Assembling one's own team of friendly experts is an especially effective way to sanewash extremism, Reiss told me, and to overturn the system through what appear to be normal channels. If the nation's most prominent group of vaccine advisers bends toward anti-vaccine, the term loses its extremist edge—and the scientists who argue, based on sound data, that vaccines are safe and effective risk being labeled anti-government. Article originally published at The Atlantic

Hundreds of CDC workers are reinstated but majority of fired public health staffers left in limbo
Hundreds of CDC workers are reinstated but majority of fired public health staffers left in limbo

Yahoo

time8 hours ago

  • Yahoo

Hundreds of CDC workers are reinstated but majority of fired public health staffers left in limbo

Supporters of the Centers for Disease Control and Prevention demonstrate outside the center's entrance in Atlanta during a rally in April. These rallies have happened weekly since the mass layoffs first started at the CDC in February. Jill Nolin/Georgia Recorder Fired workers of the Atlanta-based Centers for Disease Control and Prevention and their supporters are pushing for more public health jobs to be restored after a portion of the center's terminated workforce was reinstated this week. Many of the more than 460 workers reinstated are assigned to the National Center for Environmental Health or the National Center for HIV, Viral Hepatitis, STD and Tuberculosis Prevention, according to the Associated Press. U.S. Health Secretary Robert F. Kennedy Jr. announced plans to slash 10,000 jobs in late March, including 2,400 jobs at the CDC. The reinstated workers received a two-paragraph memorandum Wednesday from Tom Nagy, chief human capital officer with the U.S. Department of Health and Human Services, that said they were no longer part of the previously announced reduction in force, according to a copy of the memo obtained by the Georgia Recorder. 'You will not be affected by the upcoming RIF,' the memo says. Emily G. Hilliard, press secretary for the federal agency, did not respond to specific questions about the number of jobs reinstated or which CDC programs were targeted. 'Under Secretary Kennedy's leadership, the nation's critical public health functions remain intact and effective,' Hilliard said in a statement Thursday. 'The Trump Administration is committed to protecting essential services—whether it's supporting coal miners and firefighters through NIOSH, safeguarding public health through lead prevention, or researching and tracking the most prevalent communicable diseases.' Sarah Boim, a former communication specialist at the CDC who is a leader of the group Fired But Fighting, said some of the reinstated staffers were already back at work Thursday. Boim said the restored jobs are not enough, but she said she is skeptical that more people will be brought back since the newly reinstated group represents about 20% of the job losses at the CDC – which would mirror what Kennedy said earlier would need to be reversed because of 'mistakes' made by the Department of Government Efficiency. Lawsuits challenging the terminations at the CDC and other federal agencies are also working their way through the courts. Boim said the saga has left laboratory scientists and others sidelined from their work while collecting administrative pay. 'It's mind boggling — the level of inefficiency and chaos that this whole process has sown,' she said. 'I would like people to know that their money was going to pay for people with critical jobs to not do their jobs.' Georgia Democrats who have pressed for the Trump administration to reverse course on the CDC cuts cheered the news Thursday but pressed for more fired CDC workers to be brought back. 'The rehiring of hundreds of dedicated health workers, many of whom call Georgia home, is welcome news for those of us who believe that public health is vital to our wellbeing and safety — not a political game,' U.S. Sen. Raphael Warnock said in a statement. Warnock participated in a rally outside the CDC in April. Those rallies have been held every week since the mass layoffs started in February, with one held Tuesday despite the rain after Kennedy fired members of a key vaccine panel. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store